<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Bulletin of Rehabilitation Medicine</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Bulletin of Rehabilitation Medicine</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Вестник восстановительной медицины</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2078-1962</issn>
   <issn publication-format="online">2713-2625</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">68970</article-id>
   <article-id pub-id-type="doi">10.38025/2078-1962-2022-21-5-42-49</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Технологии восстановительной медицины и медицинской реабилитации</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>Rehabilitation Medicine and Medical Rehabilitation Technologies</subject>
    </subj-group>
    <subj-group>
     <subject>Технологии восстановительной медицины и медицинской реабилитации</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">The Effect of Lifestyle Correction Based on Body Composition Intervention on Clinical Efficacy: a Prospective Comparative Randomized Study of Polycystic Ovary Syndrome Patients</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Влияние изменения образа жизни на основе коррекции состава тела на клиническую эффективность: проспективное сравнительное рандомизированное исследование пациентов с синдромом поликистозных яичников</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Чжан</surname>
       <given-names>Синь-Юань. Xin-Yuan.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Чжан</surname>
       <given-names>Zhang Xin-Yuan.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Фу</surname>
       <given-names>Линг-Линг. Ling-Ling.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Фу</surname>
       <given-names>Fu Ling-Ling.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Сонг</surname>
       <given-names>Ке. Ke.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Сонг</surname>
       <given-names>Song Ke.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Хэ</surname>
       <given-names>Тинг-Тинг. Ting-Ting.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Хэ</surname>
       <given-names>He Ting-Ting.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Ян</surname>
       <given-names>Цзин. Jing.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Ян</surname>
       <given-names>Yang Jing.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Чан</surname>
       <given-names>Цзюнь. Jun.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Чан</surname>
       <given-names>Chang Jun.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Су</surname>
       <given-names>Ли. Мэн.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Meng.</surname>
       <given-names>Su Li.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Ли</surname>
       <given-names>Цзе. Jie.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Ли</surname>
       <given-names>Li Jie.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Яо</surname>
       <given-names>Лэй. Lei.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Яо</surname>
       <given-names>Yao Lei.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Чжан</surname>
       <given-names>Янь. Yan.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Чжан</surname>
       <given-names>Zhang Yan.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Лю</surname>
       <given-names>Цзян-Лин. Jiang-Ling.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Лю</surname>
       <given-names>Liu Jiang-Ling.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Первая народная больница Урумчи, Синьцзян, Китай</institution>
     <country>ru</country>
    </aff>
    <aff>
     <institution xml:lang="en">Первая народная больница Урумчи, Синьцзян, Китай</institution>
     <country>ru</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2022-10-25T14:01:20+03:00">
    <day>25</day>
    <month>10</month>
    <year>2022</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-10-25T14:01:20+03:00">
    <day>25</day>
    <month>10</month>
    <year>2022</year>
   </pub-date>
   <volume>21</volume>
   <issue>5</issue>
   <fpage>42</fpage>
   <lpage>49</lpage>
   <history>
    <date date-type="received" iso-8601-date="2022-10-12T14:01:20+03:00">
     <day>12</day>
     <month>10</month>
     <year>2022</year>
    </date>
    <date date-type="accepted" iso-8601-date="2022-10-20T14:01:20+03:00">
     <day>20</day>
     <month>10</month>
     <year>2022</year>
    </date>
   </history>
   <self-uri xlink:href="https://nmicrk.editorum.ru/en/nauka/article/68970/view">https://nmicrk.editorum.ru/en/nauka/article/68970/view</self-uri>
   <abstract xml:lang="ru">
    <p>ВВЕДЕНИЕ. Синдром поликистозных яичников – это эндокринно-метаболическое заболевание, показатели по распространённости которого постоянно растут. Он характеризуется различными клиническими составляющими, основными из которых являются избыток андрогенов, олиго-ановуляторное бесплодие, поликистоз яичников, инсулинорезистентность (ИР) и кардиометаболические изменения.&#13;
ЦЕЛЬ. Изучить клинический эффект корректировки образа жизни на основе состава тела у пациенток с синдромом поликистозных яичников.&#13;
МАТЕРИАЛ И МЕТОДЫ. В период с ноября 2020 года по июль 2021 года 91 пациентка с диагнозом синдрома полкистозных яичников в Первой народной больнице Урумчи была проспективно отобрана и разделена на контрольную (46 человек) и экспериментальную (45 человек) группы в соответствии с методом случайных чисел. Пациентки контрольной группы принимали таблетки дроспиренона и этинилэстрадиола (II), а пациентки экспериментальной группы – таблетки дроспиренона и этинилэстрадиола (II) и проходили корректировку образа жизни в зависимости от состава тела. Изменения индексов до и после 3 месяцев лечения сравнивались между двумя группами.&#13;
РЕЗУЛЬТАТЫ. Показатели пациентов с синдромом поликистозных яичников в двух группах после лечения (за исключением 1 базальной скорости метаболизма и веса мышц, 2. гонадотропный гормон и 3. ЛПВП) снизились, причем снижение в экспериментальной группе было более значительным (P &lt; 0,05). У пациенток в экспериментальной группе значительно повысился уровень спонтанной овуляции и беременности.&#13;
ЗАКЛЮЧЕНИЕ. У пациенток с синдромом поликистоза яичников комбинация таблеток Дроспиренона и Этинилэстрадиола (II) и изменения образа жизни на основе на основе коррекции состава тела может значительно улучшить репродуктивный гормон, метаболизм глюкозы и резистентность к инсулину, что благоприятно для спонтанной овуляции и беременности, а также снизить вес пациенток.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>AIM. To study the clinical effect of body composition-based lifestyle intervention in patients with polycystic ovary syndrome (PCOS).&#13;
MATERIAL AND METHODS. In the period of November, 2020 – July, 2021, 91 patients diagnosed with PCOS in the First People's Hospital of Urumqi were prospectively selected and divided into a control group (46 cases) and an experimental group (45 cases) according to random number method. The patients in the control group were treated with Drospirenone and Ethinylestradiol tablets (II), while the patients in the experimental group were treated with Drospirenone and Ethinylestradiol tablets (II) and lifestyle adjustment based on body composition. The changes of the indices before and after 3 months of treatment were compared between the two groups.&#13;
RESULTS. The indices of PCOS patients in the two groups after treatment (except 1 basal metabolic rate and muscle weight, 2. FSH and 3. HDL) were decreased, and the decrease in the experimental group was more significant (P &lt; 0.05). Patients in the experimental group had significantly increased spontaneous ovulation and pregnancy rate / Conducive to ovulation and pregnancy.&#13;
CONCLUSION. In PCOS patients, the combination of Drospirenone and Ethinylestradiol tablets (II) and lifestyle intervention based on human body components can improve reproductive hormone, glucose metabolism and insulin resistance more effectively, which is beneficial to spontaneous ovulation and pregnancy, and reduce the weight of patients.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>состав тела</kwd>
    <kwd>образ жизни</kwd>
    <kwd>синдром поликистозных яичников</kwd>
    <kwd>антимюллеров гормон</kwd>
    <kwd>инсулинорезистентность</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>body composition</kwd>
    <kwd>life style</kwd>
    <kwd>polycystic ovary syndrome</kwd>
    <kwd>Anti-Mullerian hormone</kwd>
    <kwd>Insulin resistance</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Joham Anju E., Norman Robert J., Stener-Victorin Elisabet. et al. Polycystic ovary syndrome. The Lancet Diabetes &amp; Endocrinology. 2022; 9(10): 668-680. https://doi.org/10.1016/S2213-8587(22)00163-2</mixed-citation>
     <mixed-citation xml:lang="en">Joham Anju E., Norman Robert J., Stener-Victorin Elisabet. et al. Polycystic ovary syndrome. The Lancet Diabetes &amp; Endocrinology. 2022; 9(10): 668-680. https://doi.org/10.1016/S2213-8587(22)00163-2</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Shan Hongying, Luo Renxin, Guo Xuanying. et al. Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome. Frontiers in Pharmacology. 2022; (13): 904942. https://doi.org/10.3389/fphar.2022.904942</mixed-citation>
     <mixed-citation xml:lang="en">Shan Hongying, Luo Renxin, Guo Xuanying. et al. Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome. Frontiers in Pharmacology. 2022; (13): 904942. https://doi.org/10.3389/fphar.2022.904942</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gu Yuanyuan., Zhou Guannan., Zhou Fangyue. et al. (2022). Life Modifications and PCOS: Old Story but New Tales. Frontiers in Endocrinology. 2022; (13): 808898.https://doi.org/10.3389/fendo.2022.808898</mixed-citation>
     <mixed-citation xml:lang="en">Gu Yuanyuan., Zhou Guannan., Zhou Fangyue. et al. (2022). Life Modifications and PCOS: Old Story but New Tales. Frontiers in Endocrinology. 2022; (13): 808898.https://doi.org/10.3389/fendo.2022.808898</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Katulski Krzysztof, Czyzyk Adam, Podfigurna-Stopa Agnieszka, Genazzani Andrea R, Meczekalski Blazej. Pregnancy complications in polycystic ovary syndrome patients. Gynecological Endocrinology. 2015; 31(2): 87-91. https://doi.org/10.3109/09513590.2014.974535</mixed-citation>
     <mixed-citation xml:lang="en">Katulski Krzysztof, Czyzyk Adam, Podfigurna-Stopa Agnieszka, Genazzani Andrea R, Meczekalski Blazej. Pregnancy complications in polycystic ovary syndrome patients. Gynecological Endocrinology. 2015; 31(2): 87-91. https://doi.org/10.3109/09513590.2014.974535</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Li Wencheng, Chen Lijun. Effects of nutritional therapy management on body composition, endocrine metabolism and reproductive function in patients with PCOS. Journal of Baotou Medical College. 2018; 34(02). https://doi.org/10.16833/j.cnki.jbmc.2018.02.027</mixed-citation>
     <mixed-citation xml:lang="en">Li Wencheng, Chen Lijun. Effects of nutritional therapy management on body composition, endocrine metabolism and reproductive function in patients with PCOS. Journal of Baotou Medical College. 2018; 34(02). https://doi.org/10.16833/j.cnki.jbmc.2018.02.027</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Mitra Subarna, Saharia Gautom,and Jena Saubhagya. Correlation between serum AMH levels and cardiometabolic indices in PCOS women. Indian Journal of Endocrinology and Metabolism. 2021; 6(25): 545-550. https://doi.org/10.4103/IJEM.IJEM_421_21</mixed-citation>
     <mixed-citation xml:lang="en">Mitra Subarna, Saharia Gautom,and Jena Saubhagya. Correlation between serum AMH levels and cardiometabolic indices in PCOS women. Indian Journal of Endocrinology and Metabolism. 2021; 6(25): 545-550. https://doi.org/10.4103/IJEM.IJEM_421_21</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Zhang Pingping, Zhang Xiaoping. Effects of nutritional therapy management on body composition, endocrine metabolism and reproductive function in patients with PCOS. Journal of Baotou Medical College. 2018; 34(02). https://doi.org/10.16833/j.cnki.jbmc.2018.02.027</mixed-citation>
     <mixed-citation xml:lang="en">Zhang Pingping, Zhang Xiaoping. Effects of nutritional therapy management on body composition, endocrine metabolism and reproductive function in patients with PCOS. Journal of Baotou Medical College. 2018; 34(02). https://doi.org/10.16833/j.cnki.jbmc.2018.02.027</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Budi Wiweko, Mila Maidarti, M. Dwi Priangga, Nadia Shafira, Darrell Fernando, Kanadi Sumapraja, Muharam Natadisastra, Andon Hestiantoro. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients. Journal of Assisted Reproduction and Genetics. 2014:1311-1316. https://doi.org/10.1007/s10815-014-0300-6</mixed-citation>
     <mixed-citation xml:lang="en">Budi Wiweko, Mila Maidarti, M. Dwi Priangga, Nadia Shafira, Darrell Fernando, Kanadi Sumapraja, Muharam Natadisastra, Andon Hestiantoro. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients. Journal of Assisted Reproduction and Genetics. 2014:1311-1316. https://doi.org/10.1007/s10815-014-0300-6</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Recommendations of international evidence-based guidelines for the assessment and management of polycystic ovary syndrome. Chinese Journal of Reproductive and Contraception. 2019: 259-268.</mixed-citation>
     <mixed-citation xml:lang="en">Recommendations of international evidence-based guidelines for the assessment and management of polycystic ovary syndrome. Chinese Journal of Reproductive and Contraception. 2019: 259-268.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Teede Helena J., Marie L. Misso, Michael F. Costello, Anuja Dokras, Joop Laven, Lisa Moran, Terhi Piltonen, Robert J. Norman. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clinical Endocrinology. 2018; (89): 251-268. https://doi.org/10.1111/cen.13795</mixed-citation>
     <mixed-citation xml:lang="en">Teede Helena J., Marie L. Misso, Michael F. Costello, Anuja Dokras, Joop Laven, Lisa Moran, Terhi Piltonen, Robert J. Norman. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clinical Endocrinology. 2018; (89): 251-268. https://doi.org/10.1111/cen.13795</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Wang Zheng, Henk Groen, Astrid E.P. Cantineau, Tessa M. van Elten, Matty D.A. Karsten, Anne M. van Oers, Ben W.J. Mol, Tessa J. Roseboom, Annemieke Hoek. Dietary Intake, Eating Behavior, Physical Activity, and Quality of Life in Infertile Women with PCOS and Obesity Compared with Non-PCOS Obese Controls. Nutrients. 2021; 13(10): 3526. https://doi.org/10.3390/NU13103526</mixed-citation>
     <mixed-citation xml:lang="en">Wang Zheng, Henk Groen, Astrid E.P. Cantineau, Tessa M. van Elten, Matty D.A. Karsten, Anne M. van Oers, Ben W.J. Mol, Tessa J. Roseboom, Annemieke Hoek. Dietary Intake, Eating Behavior, Physical Activity, and Quality of Life in Infertile Women with PCOS and Obesity Compared with Non-PCOS Obese Controls. Nutrients. 2021; 13(10): 3526. https://doi.org/10.3390/NU13103526</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Alizadeh Sanaz, Shahideh Jahanian Sadatmahalleh, Fatemeh Razavinia, Mahnaz Bahri Khomami, Malihe Nasiri, Ashraf Moini, Saeideh Ziaei. Metabolic parameters in cord blood of neonate of mothers with obese and non-obese PCOS and controls: retrospective cohort study. BMC Pregnancy and Childbirth. 2021; (21): 223. https://doi.org/10.1186/S12884-021-03697-6</mixed-citation>
     <mixed-citation xml:lang="en">Alizadeh Sanaz, Shahideh Jahanian Sadatmahalleh, Fatemeh Razavinia, Mahnaz Bahri Khomami, Malihe Nasiri, Ashraf Moini, Saeideh Ziaei. Metabolic parameters in cord blood of neonate of mothers with obese and non-obese PCOS and controls: retrospective cohort study. BMC Pregnancy and Childbirth. 2021; (21): 223. https://doi.org/10.1186/S12884-021-03697-6</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ye Hong. A new interpretation of weight management and lifestyle intervention in polycystic ovary syndrome. Family planning and obstetrics and gynecology in China. 2020; 12(02): 3-4.</mixed-citation>
     <mixed-citation xml:lang="en">Ye Hong. A new interpretation of weight management and lifestyle intervention in polycystic ovary syndrome. Family planning and obstetrics and gynecology in China. 2020; 12(02): 3-4.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Dong Jin-feng, Jiang Jing, Zheng Tongtong. et al. Association of insulin resistance obesity and sex hormone levels with serum anti-Müllerian hormone levels in patients with polycystic ovary syndrome. Maternal and Child Health Care of China. 2021; 36(09): 2086-2089. https://doi.org/10.19829/j.zgfybj.issn.1001-4411.2021.09.042</mixed-citation>
     <mixed-citation xml:lang="en">Dong Jin-feng, Jiang Jing, Zheng Tongtong. et al. Association of insulin resistance obesity and sex hormone levels with serum anti-Müllerian hormone levels in patients with polycystic ovary syndrome. Maternal and Child Health Care of China. 2021; 36(09): 2086-2089. https://doi.org/10.19829/j.zgfybj.issn.1001-4411.2021.09.042</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Sezai Sahmay, Begum Aydogan Mathyk, Nigar Sofiyeva, Nil Atakul, Aslı Azemi, Tamer Erela. Serum AMH levels and insulin resistance in women with PCOS. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology. 2018; (224): 159-164. https://doi.org/10.1016/j.ejogrb.2018.03.007</mixed-citation>
     <mixed-citation xml:lang="en">Sezai Sahmay, Begum Aydogan Mathyk, Nigar Sofiyeva, Nil Atakul, Aslı Azemi, Tamer Erela. Serum AMH levels and insulin resistance in women with PCOS. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology. 2018; (224): 159-164. https://doi.org/10.1016/j.ejogrb.2018.03.007</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Tang Yuzhu. et al. A multicenter prospective study on the role of Internet online lifestyle intervention in the treatment of patients with polycystic ovary syndrome based on body composition measurement. Chinese Journal of Reproductive and Contraception. 2019; (03): 177-184.</mixed-citation>
     <mixed-citation xml:lang="en">Tang Yuzhu. et al. A multicenter prospective study on the role of Internet online lifestyle intervention in the treatment of patients with polycystic ovary syndrome based on body composition measurement. Chinese Journal of Reproductive and Contraception. 2019; (03): 177-184.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Hajivandi Leila, Noroozi Mahnaz, Mostafavi Firoozeh. A comprehensive interventional program for promoting eating behaviors in adolescent girls with polycystic ovarian syndrome (PCOS): protocol for a mixed methods study. Reproductive Health. 2018; 15(1): 197 p. https://doi.org/10.1186/s12978-018-0652-y</mixed-citation>
     <mixed-citation xml:lang="en">Hajivandi Leila, Noroozi Mahnaz, Mostafavi Firoozeh. A comprehensive interventional program for promoting eating behaviors in adolescent girls with polycystic ovarian syndrome (PCOS): protocol for a mixed methods study. Reproductive Health. 2018; 15(1): 197 p. https://doi.org/10.1186/s12978-018-0652-y</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Zhang Qiaoli. Interpretation of 2018 SOGC Polycystic Ovary Syndrome Induction Practice Guide. Chinese Journal of Reproductive and Contraception. 2020; (362): 695-700.</mixed-citation>
     <mixed-citation xml:lang="en">Zhang Qiaoli. Interpretation of 2018 SOGC Polycystic Ovary Syndrome Induction Practice Guide. Chinese Journal of Reproductive and Contraception. 2020; (362): 695-700.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Dietz de Loos Alexandra LP., Jiskoot Geranne, Timman Reinier, Beerthuizen Annemerle, Busschbach Jan J.V., Laven Joop S.E. Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention. Reproductive BioMedicine Online. 2021; 43(2): 298-309. https://doi.org/10.1016/j.rbmo.2021.05.008</mixed-citation>
     <mixed-citation xml:lang="en">Dietz de Loos Alexandra LP., Jiskoot Geranne, Timman Reinier, Beerthuizen Annemerle, Busschbach Jan J.V., Laven Joop S.E. Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention. Reproductive BioMedicine Online. 2021; 43(2): 298-309. https://doi.org/10.1016/j.rbmo.2021.05.008</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Anupama Bahadur, Neha Verma, Rajlaxmi Mundhra, Latika Chawla, Megha Ajmani, Modalavalasa Swetha Sri, Shivaani Arora. Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary Syndrome. Cureus. 2021; 13(6): e16047. https://doi.org/10.7759/CUREUS.16047</mixed-citation>
     <mixed-citation xml:lang="en">Anupama Bahadur, Neha Verma, Rajlaxmi Mundhra, Latika Chawla, Megha Ajmani, Modalavalasa Swetha Sri, Shivaani Arora. Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary Syndrome. Cureus. 2021; 13(6): e16047. https://doi.org/10.7759/CUREUS.16047</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
